Back

Angiotensin II receptor antagonist fimasartan has protective role of left ventricular fibrosis and remodeling in the rat ischemic heart

8 July 2016 (09:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session 1 - Cardiomyopathies and fibrosis Cardiomyopathies Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Sung-Ji Park

Samsung Medical Center, Seoul (Korea (Republic of))

12 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Khudiakov (Cusano Milanino, IT)
Abstract
Presentation thumbnail
Doctor J. Nistal (Santander, ES)
Abstract
Presentation thumbnail
Doctor C. Ferrantini (Florence, IT)
Abstract
Presentation thumbnail
Miss S. Di Maggio (Milan, IT)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Cardiomyopathies and fibrosis

The Event

Event poster

Frontiers in CardioVascular Biology 2016

8 July 2016 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy
25 April 2024
thumbnail
Congress Presentation
Left ventricular biomechanics evaluation in the late stages of acute myocardial infarction with ST segment elevation in patients after underwent percutaneous coronary intervention
29 June 2021
thumbnail
Congress Presentation
Effects of resistance exercise in the cardiac remodeling of myocardial infarction rats
26 August 2022
thumbnail
Congress Presentation
Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction
1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources